Remote monitoring device approved for heart patients

(HealthDay)—An implanted wireless device that measures key vital signs in people with heart failure has been approved by the U.S. Food and Drug Administration.

The CardioMEMSHF system measures pulmonary artery pressure and and sends this information remotely to the patient's doctors, the FDA said Wednesday in a news release.

The device is intended for people with New York Heart Association Class III , the FDA said. Some 5.8 million people in the United States have heart failure, in which the heart can't pump enough blood. People with NYHA Class III heart failure have difficulty performing everyday tasks such as walking short distances, the agency said.

The device was evaluated in a clinical study involving 550 people. All devices implanted were still working after six months, the FDA said.

The agency said it is requiring a post-approval study to gather information about the device's long-term performance.

The system is manufactured by CardioMEMS Inc., based in Atlanta.

More information: Visit the FDA to learn more about this approval.

Related Stories

FDA approves expanded indication for CRT devices

date Apr 15, 2014

(HealthDay)—The U.S. Food and Drug Administration has approved an application from Medtronic for revised labeling for two cardiac resynchronization pacemakers (CRT-P) and eight cardiac resynchronization ...

Recommended for you

Texas the front line on high school ECG debate

date 2 hours ago

Cody Stephens was trying to shed some of the 290 pounds from his 6-foot-9 frame before graduating high school and attending his first college football training camp three summers ago when he took a nap and didn't wake up. ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.